ArticlePeerJ2026
Oil-in-water nanoemulsion-based ethyl lauroyl arginate nanoparticles exhibit potent antibacterial and antibiofilm activity against oral pathogens.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Phytosphingosine disrupts dual-species oral biofilms and attenuates LPS-induced pro-inflammatory responses in human gingival fibroblasts.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dental biofilm is a key etiological factor in oral diseases such as dental caries and periodontal disease, and has also been linked to systemic health complications. In this study, ethyl lauroyl arginate nanoparticles (ELANPs) were formulated using an oil-in-water nanoemulsion system to investigate their antibiofilm capacity and cellular cytotoxicity Methods: The morphology of ELANPs was examined using transmission electron microscopy (TEM). Particle size, polydispersity index (PDI), and zeta potential were evaluated to assess nanoparticle stability over time. Biofilm matrix reduction was analyzed using confocal laser scanning microscopy (CLSM), and cytotoxicity was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Results: ELANPs displayed a spherical morphology with an average diameter of 84.3 ± 2.6 nm. The zeta potential was 46.7 ± 4.6 mV, and the PDI was 0.18 ± 0.01, indicating good colloidal uniformity and stable nanosuspensions. Slight changes in physicochemical properties were observed at days 14 and 30, and overall stability was maintained. ELANPs significantly reduced the biofilm matrix across all tested oral pathogens while maintaining low cytotoxicity toward normal human gingival fibroblasts. Conclusion: The findings indicate that ELANPs are physicochemically stable, capable of inhibiting oral biofilm formation, and exhibit minimal cytotoxicity, supporting their potential as a safe and effective oral healthcare agent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.